The Valley Desk

ArticleJournal of the American Academy of DermatologyPublished

Prednisone dosage is the primary modifiable risk factor for infection in pemphigus with rituximab treatment: A retrospective analysis of 105 patients

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, Philadelphia VA Medical Center, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Journal of the American Academy of Dermatology
Published
Subject terms
Rituximab; Pemphigus Vulgaris; Infection Risk; Autoimmune Skin Disease; Autoimmune Blistering Disease
PubMed ID
42336211
Added to directory
Source checked

Report a correction or request removal